Mohammad Mehdi Ommati | Neuropharmacology | Innovative Research Award

Innovative Research Award

Mohammad Mehdi Ommati
School of Medicine, Linyi University, Linyi, Shandong, China
Mohammad Mehdi Ommati
Affiliation School of Medicine, Linyi University
Country China
Scopus ID 55696276900
Documents 158
Citations 5,514
h-index 40
Subject Area Neuropharmacology
Event World Neuroscientists Awards
ORCID 0000-0003-0514-2414

The Innovative Research Award recognizes researchers whose scholarly contributions have significantly advanced scientific understanding through sustained research productivity, interdisciplinary investigation, and measurable academic impact. Mohammad Mehdi Ommati has established a substantial research profile within neuropharmacology, contributing to experimental and translational investigations that have expanded knowledge regarding neurological mechanisms, pharmacological interventions, oxidative stress, and disease-related molecular pathways.[1]

Abstract

This academic recognition article examines the research achievements of Mohammad Mehdi Ommati in the field of neuropharmacology. With 158 indexed publications, 5,514 citations, and an h-index of 40, the researcher’s scholarly record demonstrates sustained productivity and broad scientific influence. The body of work reflects an emphasis on pharmacological mechanisms, experimental neuroscience, cellular protection, toxicological evaluation, and translational applications relevant to neurological disorders. These contributions provide a strong foundation for recognition within the Innovative Research Award category.[1]

Keywords

  • Neuropharmacology
  • Oxidative Stress
  • Experimental Neuroscience
  • Pharmacological Mechanisms
  • Translational Research
  • Neuroprotection

Introduction

Neuropharmacology represents a multidisciplinary scientific field that integrates neuroscience, pharmacology, molecular biology, and medicine to understand interactions between pharmaceutical agents and the nervous system. Contemporary research in this discipline contributes to the development of therapeutic strategies for neurodegenerative diseases, neurological injuries, psychiatric disorders, and toxicological conditions.[2]

Within this scientific environment, researchers who successfully combine laboratory investigation with clinically relevant applications play an important role in translating fundamental discoveries into therapeutic innovations. Mohammad Mehdi Ommati’s research portfolio reflects this translational perspective through a substantial body of peer-reviewed publications and measurable scientific impact.[1]

Research Profile

The research profile of Mohammad Mehdi Ommati demonstrates long-term engagement in biomedical and neurological investigations. Bibliometric indicators reveal a productive academic career characterized by high publication output and extensive citation activity. Such indicators are commonly used to evaluate scholarly productivity, research visibility, and scientific influence within academic communities.[1]

  • 158 indexed publications.
  • 5,514 citations.
  • An h-index of 40.
  • Primary specialization in neuropharmacology.
  • Academic affiliation with the School of Medicine, Linyi University, China.

Research Contributions

The research contributions associated with Mohammad Mehdi Ommati encompass several interconnected scientific domains that contribute to the understanding of neurological health and disease.[1]

  • Investigation of neuroprotective mechanisms associated with pharmacological compounds.
  • Research into oxidative stress and cellular damage pathways.
  • Experimental evaluation of therapeutic interventions in neurological models.
  • Analysis of toxicological processes affecting neuronal function.
  • Translation of laboratory findings into clinically relevant research frameworks.

Publications

A publication record exceeding one hundred and fifty peer-reviewed documents indicates consistent scientific activity across multiple research themes. Publication productivity in neuropharmacology frequently reflects collaborative investigation, methodological diversity, and sustained engagement with emerging biomedical challenges.[1]

Representative publication themes include neurotoxicity, antioxidant mechanisms, pharmacological regulation, neurodegenerative disease models, and translational neuroscience. Numerous studies within these categories are supported by internationally recognized publication databases and indexed literature.[3]

Research Impact

Research impact extends beyond publication quantity and includes citation performance, knowledge dissemination, scientific influence, and translational relevance. Citation counts exceeding 5,500 indicate that the researcher’s work has been frequently referenced by the scientific community, suggesting substantial engagement with the published findings.[1]

The h-index of 40 further supports the interpretation that a significant proportion of published studies have generated measurable academic influence. Bibliometric indicators should be interpreted alongside research quality, innovation, methodological rigor, and contributions to scientific advancement.[2]

Award Suitability

Several factors support the suitability of Mohammad Mehdi Ommati for recognition within the Innovative Research Award category.[1]

  1. Demonstrated excellence in neuropharmacological research.
  2. Extensive publication productivity.
  3. Strong citation performance and scholarly visibility.
  4. Evidence of interdisciplinary and translational investigation.
  5. Contributions that align with the objectives of scientific recognition programs.

Conclusion

The academic record of Mohammad Mehdi Ommati reflects sustained scientific productivity, significant citation impact, and meaningful contributions to neuropharmacological research. Through experimental investigation and translational scholarship, the researcher has contributed to advancing knowledge related to neurological disorders and therapeutic interventions. These achievements support recognition through the Innovative Research Award presented by the World Neuroscientists Awards program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Mohammad Mehdi Ommati, Author ID 55696276900. Scopus.
    https://www.scopus.com/pages/authors/55696276900
  2. Brunton, L., Hilal-Dandan, R., & Knollmann, B. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
  3. National Center for Biotechnology Information. (n.d.). Neuropharmacology literature and indexed biomedical publications.
    https://pubmed.ncbi.nlm.nih.gov/

Tanmoy Ghosh | Translational Neuroscience | Innovative Research Award

Innovative Research Award

Tanmoy Ghosh
Faculty of Pharmacy, MS Ramaiah University of Applied Sciences
Tanmoy Ghosh
Affiliation Faculty of Pharmacy, MS Ramaiah University of Applied Sciences
Country India
Scopus ID 35767725400
Documents 27
Citations 375
h-index 10
Subject Area Translational Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0001-8470-3966

The Innovative Research Award recognizes researchers whose scholarly work demonstrates sustained scientific productivity, measurable research impact, and meaningful contributions to their discipline. Tanmoy Ghosh, affiliated with the Faculty of Pharmacy at MS Ramaiah University of Applied Sciences, India, has developed a research portfolio spanning translational neuroscience and related biomedical sciences through peer-reviewed publications, interdisciplinary collaboration, and scientific dissemination.[1]

Abstract

Tanmoy Ghosh has established a consistent academic record through peer-reviewed publications, scientific collaboration, and contributions to translational neuroscience and pharmaceutical sciences. His publication profile reflects ongoing engagement in interdisciplinary biomedical research aimed at improving the understanding of disease mechanisms and therapeutic development. The available scientometric indicators demonstrate steady scholarly influence and international visibility.[1][2]

Keywords

  • Translational Neuroscience
  • Neuropharmacology
  • Drug Discovery
  • Biomedical Research
  • Experimental Therapeutics
  • Pharmaceutical Sciences

Introduction

Innovation in neuroscience increasingly relies on multidisciplinary research integrating pharmacy, molecular biology, neuroscience, and translational medicine. Academic recognition programs evaluate researchers using objective indicators including publication output, citation impact, collaboration, and scientific relevance. Such assessments encourage continued advancement of biomedical research and facilitate knowledge exchange across scientific communities.[3]

Research Profile

According to publicly available scholarly databases, Tanmoy Ghosh has authored 27 indexed publications, accumulated 375 citations, and achieved an h-index of 10. These metrics indicate sustained scholarly productivity and measurable scientific influence. His work contributes to translational neuroscience through research addressing therapeutic innovation, pharmacological mechanisms, and biomedical applications.[1]

Research Contributions

  • Publication of peer-reviewed scientific research.
  • Interdisciplinary investigation connecting pharmacy and neuroscience.
  • Contribution to translational biomedical research.
  • Participation in internationally indexed scientific literature.
  • Support for evidence-based therapeutic development.

Publications

The researcher’s scientific record includes articles indexed in international databases covering neuroscience, pharmacology, and biomedical sciences. Individual publications collectively demonstrate continuous scholarly engagement and contribute to the advancement of translational research.[1][4]

Research Impact

Science to metric indicators demonstrate measurable academic influence through citations and publication productivity. Citation performance reflects scholarly recognition within the scientific community, while the h-index illustrates balanced productivity and citation impact across multiple publications. These indicators are widely used in research evaluation and academic benchmarking.[1][3]

Award Suitability

Based on the available academic metrics and publication record, Tanmoy Ghosh demonstrates characteristics commonly evaluated for research recognition, including sustained publication activity, citation performance, interdisciplinary research, and contributions to translational neuroscience. These attributes align with the objectives of the Innovative Research Award presented through the World Neuroscientists Awards.[5]

Conclusion

Tanmoy Ghosh has developed an academic profile characterized by consistent publication output, measurable citation impact, and interdisciplinary scientific engagement. His contributions to translational neuroscience and pharmaceutical sciences illustrate sustained commitment to biomedical research and support his recognition within international academic award initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Tanmoy Ghosh, Author ID 35767725400. Scopus.
    https://www.scopus.com/pages/authors/35767725400
  2. ORCID. (n.d.). Researcher Profile: Tanmoy Ghosh.
    https://orcid.org/0000-0001-8470-3966
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  4. Crossref. (n.d.). Digital Object Identifier Foundation.
  5. World Neuroscientists Awards. (n.d.). International Research Recognition Programme.
    https://neuroscientists.net/

Shan Ping Yu | Translational Neuroscience | Innovative Research Award

Innovative Research Award

Shan Ping Yu, 
Emory University School of Medicine, Atlanta, Georgia, United States

Shan Ping Yu
Affiliation Emory University School of Medicine
Country United States
Scopus ID 36157350300
Documents 194
Citations 14,194
h-index 62
Subject Area Neuroscience, Stroke Research, Stem Cell Biology, Neurodegeneration, Translational Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0003-1335-1398

Shan Ping Yu, is an internationally recognized neuroscientist and physician-scientist affiliated with the Department of Anesthesiology at Emory University School of Medicine. His research career spans several decades and encompasses fundamental and translational investigations in neuroprotection, stroke biology, stem cell therapeutics, ion channel regulation, neurodegenerative disorders, and cellular signaling mechanisms. Through leadership in academic medicine, editorial service, grant review activities, and mentorship, Yu has contributed substantially to contemporary neuroscience research and regenerative medicine initiatives.[1]

Abstract

This academic article examines the professional achievements and scientific contributions of Shan Ping Yu, MD/PhD, whose multidisciplinary research has significantly influenced the fields of neuroscience, neurodegenerative disease biology, stroke pathology, and regenerative medicine. Yu’s investigations into ion channel signaling, neural cell death mechanisms, stem cell therapeutics, and neuroinflammation have contributed to improved understanding of brain injury and neural repair processes. His leadership roles at Emory University and multiple international scientific organizations reflect sustained engagement in advancing translational neuroscience research. The article further evaluates Yu’s publication record, editorial leadership, peer-review service, mentoring activities, and global academic collaborations in the context of scientific recognition and award suitability.[2]

Keywords

  • Neuroscience
  • Stroke Research
  • Neurodegeneration
  • Stem Cell Therapy
  • Ion Channels
  • Cell Death Mechanisms
  • Regenerative Medicine
  • Brain Injury
  • Translational Neuroscience
  • Neural Repair

Introduction

The advancement of neuroscience and neurodegenerative disease research relies heavily on interdisciplinary approaches integrating molecular biology, pharmacology, stem cell science, and translational medicine. Shan Ping Yu has contributed to these developments through extensive investigations into ischemic brain injury, neuronal cell death, neuroprotection, and stem cell-mediated recovery pathways. His scientific career spans academic appointments at Washington University, the Medical University of South Carolina, and Emory University, where he currently serves as Asa Griggs Candler Endowed Professor with tenure.[1]

Yu’s work has also emphasized the clinical relevance of molecular neuroscience discoveries, particularly in relation to stroke, traumatic brain injury, and Alzheimer’s disease research. His studies on ion channels and neuroinflammation have contributed to broader understanding of neuronal survival and regenerative signaling mechanisms.[3]

Research Profile

Shan Ping Yu obtained his MD and MS degrees from the Capital Institute of Medicine in Beijing, China, followed by a PhD from the State University of New York at Stony Brook. His postdoctoral training at the Howard Hughes Medical Institute further strengthened his expertise in neurobiology and cellular signaling mechanisms. Yu later established an internationally recognized research program focused on ischemic brain injury and neuroregeneration.[4]

At Emory University School of Medicine, Yu has led multidisciplinary projects examining molecular pathways involved in neuronal injury and neural repair. His research integrates experimental neuroscience with translational therapeutic development, particularly in stem cell-based interventions and neuroprotective pharmacology.[5]

Research Contributions

Yu has contributed substantially to the understanding of neuronal apoptosis, necrosis, oxidative stress signaling, and ionic dysregulation during cerebral ischemia. His investigations into potassium and calcium channel modulation in neuronal injury have influenced experimental stroke therapeutics and neuroprotective strategies.[5]

Another major area of contribution involves stem cell therapy for neurological disorders. Yu’s collaborative studies explored mechanisms by which stem cells facilitate neural repair and functional recovery following stroke and traumatic brain injury. These investigations have informed broader regenerative medicine strategies aimed at restoring neural circuitry after injury.[4]

Publications

Yu’s publication portfolio includes numerous peer-reviewed articles in neuroscience, pharmacology, neurochemistry, and regenerative medicine journals. His work has appeared in internationally recognized journals including Stroke, Journal of Neuroscience, PNAS, Cell Death & Disease, and Translational Stroke Research.[2]

Research Impact

Yu’s scientific impact extends across neuroscience, regenerative medicine, and translational stroke research communities. His participation in NIH, NSF, VA, and international grant review panels demonstrates recognition as an authority in neurobiology and neurological disease research. He has also supervised postdoctoral fellows and junior investigators who subsequently obtained faculty appointments and research leadership positions internationally.[1]

His mentorship activities and commitment to diversity and inclusion in STEM education have contributed to career advancement opportunities for minority scholars and international researchers. Yu’s involvement with the PATHs AGEP Alliance and mentorship of early-career investigators highlights sustained contributions to academic workforce development.[2]

Award Suitability

Shan Ping Yu’s research career demonstrates sustained excellence in neuroscience and neurodegenerative disease investigation. His extensive publication record, international scientific collaborations, editorial leadership, conference organization, grant review participation, and mentoring contributions collectively support recognition within advanced scientific award categories. His work has influenced both experimental neuroscience research and translational therapeutic development in stroke and neurodegeneration.[2]

The breadth of Yu’s contributions across academia, research administration, and scientific mentorship aligns strongly with criteria commonly associated with lifetime achievement, excellence in neuroscience research, and translational medicine awards.[3]

Conclusion

Shan Ping Yu, MD/PhD, has established a distinguished international reputation in neuroscience and regenerative medicine through decades of scholarly achievement, translational research, and scientific leadership. His work in neuroprotection, stem cell therapy, neurodegeneration, and stroke biology has contributed to improved understanding of neurological disease mechanisms and therapeutic strategies. Through mentorship, peer-review service, conference organization, and editorial activities, Yu has also strengthened global neuroscience research networks and academic training initiatives.[4]

References

  1. Emory University School of Medicine. (2025). Faculty Curriculum Vitae: Shan Ping Yu, MD/PhD.
  2. Elsevier. (n.d.). Scopus author details: Shan Ping Yu, Author ID 36157350300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36157350300
  3. ScienceDaily. (2021). Alternative model of Alzheimer’s emphasizes different mechanisms leading to neurodegeneration.
  4. State University of New York at Stony Brook. Postdoctoral and doctoral research records related to neuroscience training.
  5. Emory University School of Medicine. Department of Anesthesiology faculty profile and research overview.